<code id='166F6F0FA3'></code><style id='166F6F0FA3'></style>
    • <acronym id='166F6F0FA3'></acronym>
      <center id='166F6F0FA3'><center id='166F6F0FA3'><tfoot id='166F6F0FA3'></tfoot></center><abbr id='166F6F0FA3'><dir id='166F6F0FA3'><tfoot id='166F6F0FA3'></tfoot><noframes id='166F6F0FA3'>

    • <optgroup id='166F6F0FA3'><strike id='166F6F0FA3'><sup id='166F6F0FA3'></sup></strike><code id='166F6F0FA3'></code></optgroup>
        1. <b id='166F6F0FA3'><label id='166F6F0FA3'><select id='166F6F0FA3'><dt id='166F6F0FA3'><span id='166F6F0FA3'></span></dt></select></label></b><u id='166F6F0FA3'></u>
          <i id='166F6F0FA3'><strike id='166F6F0FA3'><tt id='166F6F0FA3'><pre id='166F6F0FA3'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:3313
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Decentralized clinical trials need collaboration to achieve wider use
          Decentralized clinical trials need collaboration to achieve wider use

          AdobeDespitegroundbreakingadvancesinbasicandclinicalscienceandtechnology,clinicaltrialmethodshavenot

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          New research sheds light on how often breast cancer is overdiagnosed

          Apatientundergoingamammogram.Newresearchsuggests1of7breastcancercasesdetectedduringscreeningsarewhat